Archive for the 'Biotech' Category

Biotech is in Play – OSI Pharmaceuiticals

The 50% premium being paid for OSIP by Astellas, which is roughly $52/share, was actually rejected by the board. The market is pricing the stock at $56, and I think the stock climbs another $10 from here. There will be another bidder.
The M&A attention is bullish for the sector. There are some good plays out [...]

Invitation to Readers to Write for Investment Capitalist

After much consideration and several suggestions from Investment Capitalist readers, I’ve decided to open Investment Capitalist up for members to write their own content, post ideas, analysis and share their charts; in addition to my content which I will continue writing.
I would also love to comment on readers trade ideas and their technical analysis work [...]

Invitation to Join New LinkedIn Group

With all of the clutter and insanity due to groups turning into recruiting grounds and advertising forums for esoteric and mindless products, I was compelled to launch my own LinkedIn Group which is being emphatically embraced by the systematic and discretionary proprietary trading universe, to my delight.
I know many of you are Prop. Traders, whether [...]